• Протек
    LEADERSHIP
    THROUGH PARTNERSHIP
  • Протек 2
    LEADERSHIP
    THROUGH PARTNERSHIP
  • Протек 4
    LEADERSHIP
    THROUGH PARTNERSHIP

News

more...

Zdravcity is at the top of the rating of associations and online resources of pharmaceutical retail business by the rates of growth

The gross sales amount of the online resource was equal to more than 6 billion rubles.

more...

Zdravcity is among the ten finalists of the “Runet Prize”

The short list of the prize, formed according to the results of voting of the Expert Board, was announced on 1 December.  more...

Sotex introduces low molecular weight heparin (nadroparin) under the Detrombin® trademark

The company is strengthening its position in the parenteral anticoagulant market by expanding its product line. more...

Construction began on a new facility of CV Protek’s logistics park near Moscow

At the end of July, construction began on a new customs warehouse terminal TST-3, constructions works for TST-4 facility are scheduled to start in September.

more...

Distribution and retail segments of Protek Group recognized as the most influential players in the pharmaceutical market

CV Protek (Protek Group distribution segment) and Rigla Pharmacy Chain (Protek Group retail segment) were recognized as the most influential players in the pharmaceutical market in 2020. more...

Protek’s CFO Mikhail Danilov Featured in Choiseul 100 Russia Rating

CV Protek’s CFO Mikhail Danilov was features in Choiseul 100 Russia rating of young economic leaders by the French independent analytical center Institut Choiseul and Observo analytical center of the Franco-Russian Chamber of Trade and Commerce in Moscow. more...

Protek Group headed the list of pharmaceutical companies in Expert-400 rating

Protek Group ranked 59th among largest Russian companies by 2019 revenue in the Expert-400 rating. more...

Protek Group ranked 57 among Russia’s 100 Largest Companies

Protek Group was ranked 57th among largest Russian companies rated by 219 revenue in the RBC-500 Rating. more...

Protek Group topped the list of pharmaceutical companies in the rating “200 largest private companies in Russia

Protek Group with a revenue of 265.6 billion rubles in 2019 was ranked 34th in the annual rating “200 largest private companies in Russia”, published on 17 September on the website of the Russian edition of Forbes magazine. more...

Показывать на странице: 10 | 30 | 50 | все
Страница: < 1 2 3 ... 10 11 >
CV Protek uses cookies (files with data about previous visits to the site) for personalization of services and convenience of users. CV Protek is serious about protecting personal data. Read the terms and principles of data processing. .
You can prevent cookies from being stored in your browser settings.
Close